Biosynex Nordic ApS — Credit Rating and Financial Key Figures
CVR number: 38417541
Strandvejen 100, 2900 Hellerup
info@medkoncept.dk
tel: 29114852
www.medkoncept.dk
Income statement (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 230.64 | 5 123.34 | 65 446.56 | 52 128.27 | -1 062.00 |
| Employee benefit expenses | - 862.32 | -1 912.04 | -3 749.58 | ||
| EBIT | 230.64 | 5 123.34 | 64 584.24 | 50 216.23 | -4 811.58 |
| Other financial income | 0.04 | 4.70 | 3 634.80 | ||
| Other financial expenses | -2.52 | -23.93 | - 812.73 | - 208.78 | - 223.79 |
| Pre-tax profit | 228.12 | 5 099.45 | 63 776.22 | 53 642.25 | -5 035.37 |
| Income taxes | -50.17 | -1 124.08 | -14 047.72 | -11 839.59 | 1 103.58 |
| Net earnings | 177.95 | 3 975.37 | 49 728.50 | 41 802.66 | -3 931.79 |
Assets (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Finished products/goods | 2 402.99 | 18 343.37 | 389.05 | 486.70 | |
| Advance payments | 5 257.52 | ||||
| Inventories total | 2 402.99 | 23 600.89 | 389.05 | 486.70 | |
| Current trade debtors | 60.38 | 7 822.86 | 58 503.19 | 68.11 | 370.91 |
| Current amounts owed by group member comp. | 9 956.26 | ||||
| Current other receivables | 1 000.00 | 12 099.93 | 58.27 | ||
| Current deferred tax assets | 31.19 | 1 134.76 | |||
| Short term receivables total | 60.38 | 7 822.86 | 69 459.46 | 12 199.23 | 1 563.94 |
| Cash and bank deposits | 444.04 | 796.90 | 5 969.07 | 2 493.77 | 1 436.27 |
| Cash and cash equivalents | 444.04 | 796.90 | 5 969.07 | 2 493.77 | 1 436.27 |
| Balance sheet total (assets) | 504.41 | 11 022.75 | 99 029.41 | 15 082.05 | 3 486.91 |
Equity and liabilities (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 400.00 | 400.00 | 400.00 |
| Shares repurchased | 3 774.54 | 39 728.50 | 42 085.04 | ||
| Other reserves | -42 085.04 | ||||
| Retained earnings | -28.78 | -3 625.37 | -49 728.50 | -42 085.04 | - 282.38 |
| Profit of the financial year | 177.95 | 3 975.37 | 49 728.50 | 41 802.66 | -3 931.79 |
| Shareholders equity total | 199.17 | 4 174.54 | 40 128.50 | 117.62 | -3 814.18 |
| Non-current owed to group member | 2 965.88 | ||||
| Non-current liabilities total | 2 965.88 | ||||
| Current trade creditors | 3 165.95 | 16 949.05 | 51.06 | 162.07 | |
| Current owed to group member | 63.20 | 43.74 | 6 891.10 | ||
| Short-term deferred tax liabilities | 43.74 | 1 124.08 | 14 047.72 | 11 870.77 | 0.00 |
| Other non-interest bearing current liabilities | 198.31 | 2 514.44 | 27 904.15 | 76.71 | 247.92 |
| Current liabilities total | 305.25 | 6 848.21 | 58 900.91 | 11 998.55 | 7 301.09 |
| Balance sheet total (liabilities) | 504.41 | 11 022.75 | 99 029.41 | 15 082.05 | 3 486.91 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.